Has Danish Qureshi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,082 in general payments to Danish Qureshi, MD across 93 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Danish Qureshi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Danish Qureshi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Danish Qureshi, MD

Interventional Pain Medicine · Pittsburgh, PANPI 1093339343

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (41.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by International Rehabilitative Sciences, Inc at 41.2% of the total. 2025 is the largest year on record at $6,030, 6.7 times the $906 reported in 2023.

$8,082in general payments, 2019–2025

Across 93 payments — averaging $86.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

International Rehabilitative Sciences, Inc$3K
Medtronic$2K
Teva Pharmaceuticals USA, Inc.$501
Alkermes, Inc.$450
Lundbeck LLC$305
Tersera Therapeutics LLC$190
plus $917 from 8 others

What the payments were for

Travel & lodging$1,69421%
Food & beverage$3,06038%
Other$3,32841%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
International Rehabilitative Sciences, Inc	1	$3,328
Medtronic	27	$2,390
Teva Pharmaceuticals USA, Inc.	13	$501
Alkermes, Inc.	15	$450
Lundbeck LLC	11	$305
Tersera Therapeutics LLC	4	$190
Bioxcel Therapeutics, Inc.	4	$190
Neurocrine Biosciences, Inc.	4	$128
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$125
Otsuka America Pharmaceutical, Inc.	1	$125
Nalu Medical, Inc.	1	$122
Johnson & Johnson	5	$108
Indivior Inc.	3	$60
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$59

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,082 in reported general payments places this provider in the 80th percentile of 59 interventional pain medicine providers in Pennsylvania.

See all interventional pain medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$3,537

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VyvanseLisdexamfetamine Dimesylate	13	$5,567
Aripiprazole	60	$1,807
Quetiapine Fumarate	89	$1,571
Methylphenidate ErMethylphenidate Hcl	12	$896
Atomoxetine Hcl	15	$838
Duloxetine Hcl	29	$812
Buspirone Hcl	48	$747
Bupropion XlBupropion Hcl	60	$667
Alprazolam	48	$560
Fluoxetine Hcl	69	$496
Clonazepam	37	$458
Divalproex Sodium	14	$338
Lorazepam	25	$233
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	13	$183
Risperidone	23	$179

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Pittsburgh

Michael FarrellPittsburgh$23K
Jorge Rivero-BecerraPittsburgh$12K
Karthik DwarkiPittsburgh$8K
Scott BrancoliniPittsburgh$6K
Thu lePittsburgh$111
Michael FishmanLebanon$670K
David ProvenzanoSewickley$198K
Farshad RashidianWest Chester$19K
Chad MetzgerDarby$14K
James BresnahanSpringfield$12K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →